The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of use of phosphodiesterase type 5 inhibitors (PDE5-I) after radical prostatectomy (RP) on biochemical recurrence-free (BCRF) and overall survival (OS): A retrospective study from the Northwestern University SPORE in prostate cancer.
 
Arden B. Roston
No Relationships to Disclose
 
Irene B. Helenowski
No Relationships to Disclose
 
William Catalona
No Relationships to Disclose
 
Robin Leikin
No Relationships to Disclose
 
Michael Gurley
Stock and Other Ownership Interests - Textractor Technologies
Consulting or Advisory Role - Textractor Technologies
Patents, Royalties, Other Intellectual Property - Developed a Case Finding tool for tumor registry operations.
 
Luke Trapp
No Relationships to Disclose
 
Borko Jovanovic
No Relationships to Disclose
 
Timothy M Kuzel
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Sanofi
Consulting or Advisory Role - Abbvie; Astellas Pharma; Genentech; Pfizer